HN Logo
Prior Authorization Protocol
VIVLODEXTM (meloxicam)



NATL
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
  1. FDA Approved Indications:
    • For management of osteoarthritis (OA) pain
  2. Health Net Approved Indications and Usage Guidelines:
    • Diagnosis of osteoarthritis or rheumatoid arthritis 

      AND
    • Failure or clinically significant adverse effect to generic meloxicam (generic Mobic) and one other preferred non-steroidal anti-inflammatory drug (NSAID) at prescription doses
  3. Coverage is Not Authorized For:
    • Non-FDA approved indications, which are not listed in the Health Net Approved Indications and Usage Guidelines section, unless there is sufficient documentation of efficacy and safety in the published literature.
  4. General Information:
    This field intentionally left blank.
  5. Therapeutic Alternatives:
    Drug Dosing Regimen Dose Limit/ Maximum Dose

    meloxicam (MobicR)

    7.5 mg - 15 mg PO QD

    15 mg/day

    etodolac (LodineR)

    400 - 500 mg PO BID

    1200 mg/day

    fenoprofen (NalfonR)

    200 mg PO Q4-6hr

    3200 mg/day

    ibuprofen (MotrinR)

    400 - 800 mg PO Q6-8hr

    3200 mg/day

    indomethacin (IndocinR)

    25 - 50 mg PO BID-TID

    200 mg/day

    indomethacin SR (IndocinR SR)

    75 mg PO QD - BID

    150 mg/day

    ketoprofen (OrudisR)

    25 - 75 mg PO Q6-8hr

    300 mg/day

    meclofenamate (MeclomenR)

    50 - 100 mg PO Q4-6hr

    400 mg/day

    diclofenac sodium (VoltarenR)

    50 mg PO TID

    150 mg/day

    naproxen (NaprosynR)

    250 - 500 mg PO BID

    1500 mg/day

    naproxen sodium (AnaproxR, Anaprox DSR)

    275 - 550 mg PO BID

    1650 mg/day

    oxaprozin

    600 - 1200 mg PO QD

    1800 mg/day

    piroxicam (FeldeneR)

    10 - 20 mg PO QD

    20 mg/day

    salsalate (DisalcidR)

    500 - 750 mg PO BID - TID,
    titrated up to 3000 mg/day

    3000 mg/day

    sulindac (ClinorilR)

    150 mg - 200 mg PO BID

    400 mg/day

    tolmetin (TolectinR)

    400 mg PO TID, titrated up to 1800 mg/day

    1800 mg/day

    * Requires Prior Authorization
  6. Recommended Dosing Regimen and Authorization Limit:
    Drug Dosing Regimen Authorization Limit

    Vivlodex

    5 mg PO QD

    May increase to 10 mg PO QD

    Length of benefit

  7. Product Availability:
    Capsules: 5 mg, 10 mg
  8. References:
    1. VivlodexTM [prescribing information]. Philadelphia, PA: Iroko Pharmaceuticals LLC; October 2015.
    2. MicromedexR Healthcare Series [Internet database]. Greenwood Village, Colo: Thompson Healthcare. Updated periodically. Accessed May 2016.
The material provided to you are guidelines used by this plan to authorize, modify or determine coverage for persons with similar illnesses or conditions. Specific care and treatment may vary depending on individual need and the benefits covered under your contract.